BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 10850311)

  • 1. Gallium-67 scintigraphy in the management: Hodgkin's disease and non-Hodgkin's lymphoma.
    Rehm PK
    Cancer Biother Radiopharm; 1999 Aug; 14(4):251-62. PubMed ID: 10850311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of gallium-67-citrate and thallium-201 scintigraphy in peripheral and intrathoracic lymphoma.
    Waxman AD; Eller D; Ashook G; Ramanna L; Brachman M; Heifetz L; McAndrews P; Bierman H; Taub R; Avedo M; Wall F
    J Nucl Med; 1996 Jan; 37(1):46-50. PubMed ID: 8544000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three cases demonstrating the role of gallium scanning in relapsing Hodgkin's disease and non-Hodgkin lymphoma.
    Zollars LE; Nagel JS; Tumeh SS
    J Nucl Med; 1987 Oct; 28(10):1611-5. PubMed ID: 3655913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of technetium-99m tetrofosmin and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
    Yang CC; Sun SS; Lin CC; Kao CH; Lee CC
    Anticancer Res; 2001; 21(5):3695-8. PubMed ID: 11848545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gallium-67 scintiscan in the diagnosis of primary splenic non-Hodgkin's lymphoma after the treatment of Hodgkin's disease.
    Lee JD; Park CH; Griffith J; Vernick J
    J Nucl Med; 1992 Jun; 33(6):1183-5. PubMed ID: 1597736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The continuing clinical role of gallium 67 scintigraphy in the age of receptor imaging.
    Front D; Bar-Shalom R; Israel O
    Semin Nucl Med; 1997 Jan; 27(1):68-74. PubMed ID: 9122725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hodgkin's disease: internal mammary lymph nodes relapse diagnosed by gallium-67 scintigraphy.
    Ruíz Hernández G; Pallardó Y; García Conde J; Ramos D; Ampudia J; Castillo FJ; Romero C
    Nuklearmedizin; 1999 Apr; 38(3):90-4. PubMed ID: 10320995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of residual mediastinal-hilar Ga-67 uptake after treatment for Hodgkin's and non-Hodgkin's lymphomas: what degree of Ga-67 uptake is significant?
    Nikpoor N; Aliabadi P; Diaz L; Mannting F
    Clin Nucl Med; 2000 Dec; 25(12):959-62. PubMed ID: 11129161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relevance of gallium-67 scintigraphy in lymphoma before and after therapy.
    Delcambre C; Reman O; Henry-Amar M; Peny AM; Macro M; Cheze S; Génot JY; Tanguy A; Switsers O; Van HL; Couëtte JE; Leporrier M; Bardet S
    Eur J Nucl Med; 2000 Feb; 27(2):176-84. PubMed ID: 10755723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of bone and 67Ga scintigraphy in the initial diagnosis of bone involvement in children with malignant lymphoma.
    Mouratidis B; Gilday DL; Ash JM
    Nucl Med Commun; 1994 Mar; 15(3):144-7. PubMed ID: 8190402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose gallium imaging in lymphoma.
    Anderson KC; Leonard RC; Canellos GP; Skarin AT; Kaplan WD
    Am J Med; 1983 Aug; 75(2):327-31. PubMed ID: 6881185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary: PET poised to alter the current paradigm for response assessment of non-Hodgkin's lymphoma.
    Guermazi A; Juweid ME
    Br J Radiol; 2006 May; 79(941):365-7. PubMed ID: 16632614
    [No Abstract]   [Full Text] [Related]  

  • 13. Gallium-67 and technetium-99m-MDP scintigraphy for osseous involvement in lymphoma.
    Van de Wiele C; Dierckx RA; Simons M; Noens L
    J Nucl Med; 1996 Mar; 37(3):548. PubMed ID: 8772667
    [No Abstract]   [Full Text] [Related]  

  • 14. [The value of gallium scintigraphy after the therapy of Hodgkin's disease].
    Staar S
    Strahlenther Onkol; 1998 Dec; 174(12):640-1. PubMed ID: 9879352
    [No Abstract]   [Full Text] [Related]  

  • 15. Ga-67 scintigraphy in a rare case of primary pleural Hodgkin's lymphoma.
    Bernstine H; Bar-Sever Z; Ekstein J; Hardoff R
    Clin Nucl Med; 1999 Nov; 24(11):880-1. PubMed ID: 10551472
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of Ga-67 scintigraphy in evaluating the results of therapy of lymphoma patients.
    Front D; Israel O
    Semin Nucl Med; 1995 Jan; 25(1):60-71. PubMed ID: 7716559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of gallium-67 scintigraphy in low-grade non-Hodgkin's lymphoma.
    Ben-Haim S; Bar-Shalom R; Israel O; Haim N; Epelbaum R; Ben-Shachar M; Gaitini D; Kolodny GM; Front D
    J Clin Oncol; 1996 Jun; 14(6):1936-42. PubMed ID: 8656263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visualization of esophageal non-Hodgkin's lymphoma with Ga-67 scintigraphy.
    Nishryama Y; Yamamoto Y; Ono Y; Satoh K; Ohkawa M; Yamauchi A; Tanabe M
    Ann Nucl Med; 1999 Dec; 13(6):419-21. PubMed ID: 10656277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gallium-67-citrate scintigraphy of high-grade T-cell non-Hodgkin's lymphoma.
    Lipp RW; Sill H; Aigner R; Ranner G; Hoefler G; Passath A; Leb G
    J Nucl Med; 1996 Sep; 37(9):1524-5. PubMed ID: 8790208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphoma: predictive value of Ga-67 scintigraphy after treatment.
    Front D; Ben-Haim S; Israel O; Epelbaum R; Haim N; Even-Sapir E; Kolodny GM; Robinson E
    Radiology; 1992 Feb; 182(2):359-63. PubMed ID: 1732950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.